Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA. 2007 Sep 12; 298(10):1189-95.
View in:
PubMed
subject areas
Cardiac Output, Low
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Myocardial Infarction
Randomized Controlled Trials as Topic
Risk
Thiazolidinediones
authors with profiles
Sonal Singh MD, MPH